> top > docs > PubMed:17151160 > annotations

PubMed:17151160 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T16 1700-1756 Sentence denotes Olanzapine may have an advantage for motor side effects.
T17 1757-1856 Sentence denotes Both medications caused substantial rapid weight gain, but weight gain was greater with olanzapine.
T1 0-104 Sentence denotes Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia:
T2 105-122 Sentence denotes 4-month outcomes.
T3 123-133 Sentence denotes OBJECTIVE:
T4 134-280 Sentence denotes The authors compared 4-month treatment outcomes for olanzapine versus risperidone in patients with first-episode schizophrenia spectrum disorders.
T5 281-288 Sentence denotes METHOD:
T6 289-562 Sentence denotes One hundred twelve subjects (70% male; mean age=23.3 years [SD = 5.1]) with first-episode schizophrenia (75%), schizophreniform disorder (17%), or schizoaffective disorder (8%) were randomly assigned to treatment with olanzapine (2.5-20 mg/day) or risperidone (1-6 mg/day).
T7 563-571 Sentence denotes RESULTS:
T8 572-707 Sentence denotes Response rates did not significantly differ between olanzapine (43.7%, 95% CI=28.8%-58.6%) and risperidone (54.3%, 95% CI=39.9%-68.7%).
T9 708-919 Sentence denotes Among those responding to treatment, more subjects in the olanzapine group (40.9%, 95% CI=16.8%-65.0%) than in the risperidone group (18.9%, 95% CI=0%-39.2%) had subsequent ratings not meeting response criteria.
T10 920-1024 Sentence denotes Negative symptom outcomes and measures of parkinsonism and akathisia did not differ between medications.
T11 1025-1148 Sentence denotes Extrapyramidal symptom severity scores were 1.4 (95% CI=1.2-1.6) with risperidone and 1.2 (95% CI=1.0-1.4) with olanzapine.
T12 1149-1385 Sentence denotes Significantly more weight gain occurred with olanzapine than with risperidone: the increase in weight at 4 months relative to baseline weight was 17.3% (95% CI=14.2%-20.5%) with olanzapine and 11.3% (95% CI=8.4%-14.3%) with risperidone.
T13 1386-1581 Sentence denotes Body mass index at baseline and at 4 months was 24.3 (95% CI=22.8-25.7) versus 28.2 (95% CI=26.7-29.7) with olanzapine and 23.9 (95% CI=22.5-25.3) versus 26.7 (95% CI=25.2-28.2) with risperidone.
T14 1582-1594 Sentence denotes CONCLUSIONS:
T15 1595-1699 Sentence denotes Clinical outcomes with risperidone were equal to those with olanzapine, and response may be more stable.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
3660 25-35 ChemicalEntity denotes olanzapine MESH:C076029
3661 43-54 ChemicalEntity denotes risperidone MESH:D018967
3662 90-103 DiseaseOrPhenotypicFeature denotes schizophrenia MESH:D012559
3663 186-196 ChemicalEntity denotes olanzapine MESH:C076029
3664 204-215 ChemicalEntity denotes risperidone MESH:D018967
3665 247-260 DiseaseOrPhenotypicFeature denotes schizophrenia MESH:D012559
3666 379-392 DiseaseOrPhenotypicFeature denotes schizophrenia MESH:D012559
3667 400-425 DiseaseOrPhenotypicFeature denotes schizophreniform disorder MESH:D011618
3668 436-460 DiseaseOrPhenotypicFeature denotes schizoaffective disorder MESH:D011618
3669 507-517 ChemicalEntity denotes olanzapine MESH:C076029
3670 537-548 ChemicalEntity denotes risperidone MESH:D018967
3671 624-634 ChemicalEntity denotes olanzapine MESH:C076029
3672 667-678 ChemicalEntity denotes risperidone MESH:D018967
3673 766-776 ChemicalEntity denotes olanzapine MESH:C076029
3674 823-834 ChemicalEntity denotes risperidone MESH:D018967
3675 962-974 DiseaseOrPhenotypicFeature denotes parkinsonism MESH:D010302
3676 979-988 DiseaseOrPhenotypicFeature denotes akathisia MESH:D017109
3677 1025-1047 DiseaseOrPhenotypicFeature denotes Extrapyramidal symptom MESH:D001480
3678 1095-1106 ChemicalEntity denotes risperidone MESH:D018967
3679 1137-1147 ChemicalEntity denotes olanzapine MESH:C076029
3680 1168-1179 DiseaseOrPhenotypicFeature denotes weight gain MESH:D015430
3681 1194-1204 ChemicalEntity denotes olanzapine MESH:C076029
3682 1215-1226 ChemicalEntity denotes risperidone MESH:D018967
3683 1327-1337 ChemicalEntity denotes olanzapine MESH:C076029
3684 1373-1384 ChemicalEntity denotes risperidone MESH:D018967
3685 1494-1504 ChemicalEntity denotes olanzapine MESH:C076029
3686 1569-1580 ChemicalEntity denotes risperidone MESH:D018967
3687 1618-1629 ChemicalEntity denotes risperidone MESH:D018967
3688 1655-1665 ChemicalEntity denotes olanzapine MESH:C076029
3689 1700-1710 ChemicalEntity denotes Olanzapine MESH:C076029
3690 1799-1810 DiseaseOrPhenotypicFeature denotes weight gain MESH:D015430
3691 1816-1827 DiseaseOrPhenotypicFeature denotes weight gain MESH:D015430
3692 1845-1855 ChemicalEntity denotes olanzapine MESH:C076029

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 90-106 DiseaseOrPhenotypicFeature denotes schizophrenia: 4 0010943
T2 90-103 DiseaseOrPhenotypicFeature denotes schizophrenia 0005090
T3 247-260 DiseaseOrPhenotypicFeature denotes schizophrenia 0005090
T4 379-392 DiseaseOrPhenotypicFeature denotes schizophrenia 0005090
T5 400-425 DiseaseOrPhenotypicFeature denotes schizophreniform disorder 0001265
T6 436-460 DiseaseOrPhenotypicFeature denotes schizoaffective disorder 0005487

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 1244-1255 GeneOrGeneProduct denotes weight at 4
T2 1386-1401 GeneOrGeneProduct denotes Body mass index
T3 1737-1742 GeneOrGeneProduct denotes motor
T4 1743-1747 GeneOrGeneProduct denotes side

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 281-287 GeneOrGeneProduct denotes METHOD
T2 322-326 GeneOrGeneProduct denotes male
T3 342-347 GeneOrGeneProduct denotes years
T4 426-435 GeneOrGeneProduct denotes (17%), or
T5 519-522 GeneOrGeneProduct denotes 2.5
T6 526-528 GeneOrGeneProduct denotes mg
T7 554-556 GeneOrGeneProduct denotes mg
T8 889-900 GeneOrGeneProduct denotes not meeting
T9 1244-1255 GeneOrGeneProduct denotes weight at 4
T10 1386-1401 GeneOrGeneProduct denotes Body mass index
T11 1414-1422 GeneOrGeneProduct denotes and at 4
T12 1737-1742 GeneOrGeneProduct denotes motor
T13 1743-1747 GeneOrGeneProduct denotes side

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 90-103 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T2 247-260 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T3 379-392 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T4 400-425 DiseaseOrPhenotypicFeature denotes schizophreniform disorder D011618
T5 436-460 DiseaseOrPhenotypicFeature denotes schizoaffective disorder D011618
T6 962-974 DiseaseOrPhenotypicFeature denotes parkinsonism D020734
T7 979-988 DiseaseOrPhenotypicFeature denotes akathisia D011595
T8 1168-1179 DiseaseOrPhenotypicFeature denotes weight gain D015430
T9 1799-1810 DiseaseOrPhenotypicFeature denotes weight gain D015430
T10 1816-1827 DiseaseOrPhenotypicFeature denotes weight gain D015430

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 1244-1255 GeneOrGeneProduct denotes weight at 4

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 90-106 DiseaseOrPhenotypicFeature denotes schizophrenia: 4 0010943
T2 247-260 DiseaseOrPhenotypicFeature denotes schizophrenia 0005090
T3 349-351 DiseaseOrPhenotypicFeature denotes SD 0011449
T4 379-392 DiseaseOrPhenotypicFeature denotes schizophrenia 0005090
T5 400-425 DiseaseOrPhenotypicFeature denotes schizophreniform disorder 0001265
T6 436-460 DiseaseOrPhenotypicFeature denotes schizoaffective disorder 0014092|0005487|0005090

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 90-103 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T2 247-260 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T3 379-392 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T4 400-425 DiseaseOrPhenotypicFeature denotes schizophreniform disorder D011618
T5 436-460 DiseaseOrPhenotypicFeature denotes schizoaffective disorder D011618
T6 962-974 DiseaseOrPhenotypicFeature denotes parkinsonism D020734
T7 979-988 DiseaseOrPhenotypicFeature denotes akathisia D011595
T8 1025-1047 DiseaseOrPhenotypicFeature denotes Extrapyramidal symptom DISEASE
T9 1168-1179 DiseaseOrPhenotypicFeature denotes weight gain D015430
T10 1799-1810 DiseaseOrPhenotypicFeature denotes weight gain D015430
T11 1816-1827 DiseaseOrPhenotypicFeature denotes weight gain D015430

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 90-103 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T2 247-260 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T3 379-392 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T4 400-425 DiseaseOrPhenotypicFeature denotes schizophreniform disorder D011618
T5 436-460 DiseaseOrPhenotypicFeature denotes schizoaffective disorder D011618
T6 962-974 DiseaseOrPhenotypicFeature denotes parkinsonism D020734
T7 979-988 DiseaseOrPhenotypicFeature denotes akathisia D011595
T8 1025-1047 DiseaseOrPhenotypicFeature denotes Extrapyramidal symptom DISEASE
T9 1168-1179 DiseaseOrPhenotypicFeature denotes weight gain D015430
T10 1799-1810 DiseaseOrPhenotypicFeature denotes weight gain D015430
T11 1816-1827 DiseaseOrPhenotypicFeature denotes weight gain D015430

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 25-35 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T3 43-54 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T5 186-196 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T7 204-215 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T9 507-517 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T11 537-548 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T13 624-634 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T15 667-678 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T17 766-776 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T19 823-834 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T21 1095-1106 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T23 1137-1147 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T25 1194-1204 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T27 1215-1226 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T29 1327-1337 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T31 1373-1384 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T33 1494-1504 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T35 1569-1580 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T37 1618-1629 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T39 1655-1665 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T41 1700-1710 ChemicalEntity denotes Olanzapine http://purl.obolibrary.org/obo/CHEBI_7735
T42 1845-1855 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 219-227 OrganismTaxon denotes patients

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T42 1845-1855 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T41 1700-1710 ChemicalEntity denotes Olanzapine http://purl.obolibrary.org/obo/CHEBI_7735
T39 1655-1665 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T37 1618-1629 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T35 1569-1580 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T33 1494-1504 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T31 1373-1384 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T29 1327-1337 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T27 1215-1226 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T25 1194-1204 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T23 1137-1147 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T21 1095-1106 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T19 823-834 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T17 766-776 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T15 667-678 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T13 624-634 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T11 537-548 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T9 507-517 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T7 204-215 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T5 186-196 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T3 43-54 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T1 25-35 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T78543 1244-1255 GeneOrGeneProduct denotes weight at 4
T11486 1816-1827 DiseaseOrPhenotypicFeature denotes weight gain D015430
T10 1799-1810 DiseaseOrPhenotypicFeature denotes weight gain D015430
T17021 1168-1179 DiseaseOrPhenotypicFeature denotes weight gain D015430
T8 1025-1047 DiseaseOrPhenotypicFeature denotes Extrapyramidal symptom DISEASE
T19469 979-988 DiseaseOrPhenotypicFeature denotes akathisia D011595
T6 962-974 DiseaseOrPhenotypicFeature denotes parkinsonism D020734
T6309 436-460 DiseaseOrPhenotypicFeature denotes schizoaffective disorder D011618
T4 400-425 DiseaseOrPhenotypicFeature denotes schizophreniform disorder D011618
T55150 379-392 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T2 247-260 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T53300 90-103 DiseaseOrPhenotypicFeature denotes schizophrenia D012559
T71762 219-227 OrganismTaxon denotes patients

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 247-260 HP_0100753 denotes schizophrenia